{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:52:19Z","timestamp":1759963939545,"version":"3.44.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"11-12","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100013213","name":"ARUP Institute for Clinical and Experimental Pathology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013213","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.cca.2011.02.031","type":"journal-article","created":{"date-parts":[[2011,3,7]],"date-time":"2011-03-07T14:02:50Z","timestamp":1299506570000},"page":"1100-1105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Diagnostic assays for Anti-PM\/Scl IgG antibodies: Heterogeneity in antibody response or lack of standardization?"],"prefix":"10.1016","volume":"412","author":[{"given":"Troy D.","family":"Jaskowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry R.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne E.","family":"Tebo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2011.02.031_bb0005","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/BF00915286","article-title":"Antibodies to a nuclear\/nucleolar antigen in patients with polymyositis overlap syndromes","volume":"4","author":"Reichlin","year":"1984","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.cca.2011.02.031_bb0010","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1084\/jem.173.4.941","article-title":"Molecular characterization of an autoantigen of PM-Scl in the polymyositis\/scleroderma overlap syndrome: a unique and complete human cDNA encoding an apparent 75-kD acidic protein of the nucleolar complex","volume":"173","author":"Alderuccio","year":"1991","journal-title":"J Exp Med"},{"key":"10.1016\/j.cca.2011.02.031_bb0015","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1084\/jem.176.4.973","article-title":"Cloning and characterization of the cDNA coding for a polymyositis-scleroderma overlap syndromerelated nucleolar 100-kD protein","volume":"176","author":"Bl\u00fcthner","year":"1992","journal-title":"J Exp Med"},{"key":"10.1016\/j.cca.2011.02.031_bb0020","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/ar389","article-title":"Autoantibodies directed to novel components of the PM\/Scl complex, the human exosome","volume":"4","author":"Brouwer","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1016\/j.cca.2011.02.031_bb0025","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/art.1780351014","article-title":"Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations","volume":"35","author":"Oddis","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2011.02.031_bb0030","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/ard.60.2.116","article-title":"Autoantibody profiles in the sera of European patients with myositis","volume":"60","author":"Brouwer","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2011.02.031_bb0035","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/art.20056","article-title":"PM\u2013Scl-75 is the main autoantigen in patients with the polymyositis\/scleroderma overlap syndrome","volume":"50","author":"Raijmakers","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2011.02.031_bb0040","doi-asserted-by":"crossref","first-page":"R22","DOI":"10.1186\/ar2614","article-title":"Antibodies against PM\/Scl-75 and PM\/Scl-100 are independent markers for different subsets of systemic sclerosis patients","volume":"11","author":"Hanke","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cca.2011.02.031_bb0045","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00005792-199211000-00001","article-title":"The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM\u2013Scl","volume":"71","author":"Marguerie","year":"1992","journal-title":"Medicine"},{"key":"10.1016\/j.cca.2011.02.031_bb0050","first-page":"129","article-title":"Anti-pm\/scl antibodies in connective tissue disease: clinical and biological assessment of 14 patients","volume":"24","author":"Vandergheynst","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.cca.2011.02.031_bb0055","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/art.1780370111","article-title":"Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis","volume":"37","author":"Kuwana","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2011.02.031_bb0060","first-page":"477","article-title":"Characterization of antinucleolar antibody reactivity in patients with systemic sclerosis and their relatives","volume":"24","author":"Harvey","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cca.2011.02.031_bb0065","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.4049\/jimmunol.137.12.3802","article-title":"Immunolocalization and partial characterization of a nucleolar autoantigen (PM-Scl) associated with polymyositis\/scleroderma overlap syndromes","volume":"137","author":"Reimer","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.cca.2011.02.031_bb0070","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2249.1990.tb05291.x","article-title":"Identification of protein components reactive with anti-PM\/Scl autoantibodies","volume":"81","author":"Gelpi","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cca.2011.02.031_bb0075","first-page":"80","article-title":"The clinical relevance of autoantibodies in scleroderma","volume":"5","author":"Ho","year":"2003","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cca.2011.02.031_bb0080","doi-asserted-by":"crossref","first-page":"R704","DOI":"10.1186\/ar1729","article-title":"Clinical evaluation of autoantibodies to a novel PM\/Scl peptide antigen","volume":"7","author":"Mahler","year":"2005","journal-title":"Arthritis Res Ther"},{"year":"1981","series-title":"Statistical methods for rates and proportions","author":"Fleiss","key":"10.1016\/j.cca.2011.02.031_bb0085"},{"key":"10.1016\/j.cca.2011.02.031_bb0090","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/bmj.314.7080.572","article-title":"Statistics notes: Crohnbach's alpha","volume":"314","author":"Bland","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.cca.2011.02.031_bb0095","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.revmed.2006.05.015","article-title":"Anti PM\u2013Scl antibodies. Study of prevalence and of meaning","volume":"27","author":"Gaudin","year":"2006","journal-title":"Rev M\u00e9d Interne"},{"key":"10.1016\/j.cca.2011.02.031_bb0100","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/1529-0131(199707)40:7<1257::AID-ART10>3.0.CO;2-R","article-title":"Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies","volume":"40","author":"Hausmanowa-Petrusewicz","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2011.02.031_bb0105","doi-asserted-by":"crossref","first-page":"R78","DOI":"10.1186\/ar2276","article-title":"Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes","volume":"9","author":"Koenig","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cca.2011.02.031_bb0110","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1002\/art.22043","article-title":"Nucleolar staining cannot be used as a screening test for the scleroderma marker anti-RNA polymerase I\/III antibodies","volume":"54","author":"Yamasaki","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2011.02.031_bb0115","first-page":"1729","article-title":"Anti-PM\/Scl autoantibodies in patients without clinical polymyositis or scleroderma","volume":"23","author":"Schnitz","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cca.2011.02.031_bb0120","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2011.02.031_bb0125","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1093\/rheumatology\/keq281","article-title":"Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay","volume":"49","author":"Ghirardello","year":"2010","journal-title":"Rheumatol Oxf"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898111001227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898111001227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:42:57Z","timestamp":1757860977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898111001227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":25,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0009898111001227"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2011.02.031","relation":{},"ISSN":["0009-8981"],"issn-type":[{"type":"print","value":"0009-8981"}],"subject":[],"published":{"date-parts":[[2011,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic assays for Anti-PM\/Scl IgG antibodies: Heterogeneity in antibody response or lack of standardization?","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2011.02.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}